However, we did not use enrichment of neural-derived EVs by the L1CAM antibodies as done in other studies in AD and PD [60,63], to keep the isolation protocol simple and reproducible, particularly when two different species were included in our study. This evidence concerns the gene L1CAM and Parkinson disease.